References
- Böhm, B.H. and Müller, R.H., 1999. Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs. Pharmaceutical science & technology today, 2, 336–339.
- Cai, J., et al., 2012. Bone-targeting glycol and NSAIDS ester prodrugs of rhein: synthesis, hydeoxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies. European journal of medicinal chemistry, 55, 409–419.
- Cao, Y., et al., 2011. Determination of dissociation constents and apparent oil/water partition coefficient of syringopicroside. Chinese journal of experimental traditional medical formulae, 17, 65–67.
- Duraipandiyan, V., et al., 2012. Anticaner activity of rhein isolated from Cassia fistula L. flower. Asian Pacific journal of tropical disease, 2, 517–523.
- Fu, Q., et al., 2016. Further improvement of oral bioavailability for nisoldipine using nanocrystals. Powder technology, 305, 757–763.
- Gao, Y., et al., 2014. Rhein exerts pro- and anti-inflammatory actions by targeting IKKβ inhibition in LPS-activated macrophages. Free radical biology and medicine, 72, 104–112.
- Hao, L., et al., 2012. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. International journal of pharmaceutics, 433, 157–164.
- He, Z.H., et al., 2011. Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine : international journal of phytotherapy and phytopharmacology, 18, 470–478.
- Heo, S.K., et al., 2010. Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production. Vascular pharmacology, 53, 28–37.
- Jackson, C.L. and Mckenna, G.B., 1990. The melting behavior of organic materials confined in porous solids. Journal of chemical physics, 93, 9002–9010.
- Jiang, T., et al., 2012. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug development and industrial pharmacy, 38, 1230–1239.
- Karadag, A., Ozcelik, B., and Huang, Q., 2014. Quercetin nanosuspensions produced by high-pressure homogenization. Journal of agricultural and food chemistry, 62, 1852–1859.
- Kaur, K., Kaur, R., and Dhir, N., 2014. Synthesis and biological evaluation of amino acid and peptide conjugates of rhein derivatives. Journal of advanced pharmacy education & research, 4, 311–318.
- Kim, Y.M., et al., 2004. Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi. Journal of agricultural and food chemistry, 52, 6096–6100.
- Li, Y., et al., 2012. Rhein induces apoptosis of human gastric cancer SGC-7901 cells via an intrinsic mitochondrial pathway. Brazilian journal of medical and biological research, 45, 1052–1059.
- Lin, H., Qin, F., and Gao, J., 2012. Determination of equilibrium solubility and apparent oil/water partition coefficient of ursolic acid. Chinese journal of modern applied pharmacy, 7, 635–637.
- Manosroi, J., et al., 2013. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide. Drug development and industrial pharmacy, 39, 520–525.
- Manosroi, J., et al., 2014. Novel application of polioviral capsid: development of a potent and prolonged oral calcitonin using polioviral binding ligand and Tat peptide. Drug development and industrial pharmacy, 7, 65–70.
- Martena, V., et al., 2014. Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals. Drug development and industrial pharmacy, 40, 1199–1205.
- Mishra, P.R., et al., 2009. Production and characterization of hesperetin nanosuspensions for dermal delivery. International journal of pharmaceutics, 371, 182–189.
- Mohammed, S.. 2008. The pharmacological actions of naturally occurring 1, 8-dihydroxy anthraquinone derivatives. European journal of organic chemistry, 4, 495–505.
- Müller, R.H., Jacobs, C., and Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Advanced drug delivery reviews, 47, 3–19.
- Peng, Y., Sun, J., and Wang, G., 2009. Pharmacokinetic study of Rhein and its carboxyl-esterification derivatives in rats. Chinese journal of natural medicines, 7, 228–233.
- Scholz, P. and Keck, C.M., 2015. Nanocrystals: From raw material to the final formulated oral dosage form-a review. Current pharmaceutical design, 21, 4217–4228.
- Shah, D.A., Murdande, S.B. and Dave, R.H., 2016. A review: pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions. Journal of pharmaceutical sciences, 105, 10–24.
- Su, J., et al., 2013. Chronic allograft nephropathy in rats is improved by the intervention of rhein. Transplantation proceedings, 45, 2546–2552.
- Wang, Y., et al., 2011. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension. Colloids and surfaces. B, biointerfaces, 83, 189–197.
- Wang, J., et al., 2015. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis. Apoptosis, 20, 399–409.
- Wang, Y., et al., 2017. Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer. Drug development and industrial pharmacy, 43, 132–141.
- Wei, L., et al., 2015. Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug development and industrial pharmacy, 41, 1343–1352.
- Wu, C.H., et al., 2001. Inhibitory effects of Cassia tora L. on benzo[a]pyrene-mediated DNA damage toward HepG2 Cells. Journal of agricultural and food chemistry, 49, 2579–2586.
- Yang, H., et al., 2014. Investigation of a nanosuspension stabilized by Soluplus1 to improve bioavailability. International journal of pharmaceutics, 477, 88–95.
- Ye, M., et al., 2013. Synthesis, cytotoxicity, DNA binding and apoptosis of rhein-phosphonate derivatives as antitumor agents. International journal of molecular sciences, 14, 9424–9439.
- Ye, Y., et al., 2015. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug development and industrial pharmacy, 9, 1–9.